Inventor · disambiguated record
Christopher A. D'Souza
Also filed as: D SOUZA CHRISTOPHER A · D'SOUZA CHRISTOPHER
20 granted patents·4 pending applications·320 citations·filing 2008–2023
96Inventor score
Top patents by PatentIndex Score
24 records- 0198US7993626B2Methods and compositions for F-18 labeling of proteins, peptides and other moleculesIMMUNOMEDICS INC·Filed 2008·Granted Aug 9, 2011·37 cites·16 claims
- 0297US8808665B2In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agentsIMMUNOMEDICS INC·Filed 2013·Granted Aug 19, 2014·17 cites·13 claims
- 0397US8444956B2Methods and compositions for improved F-18 labeling of proteins, peptides and other moleculesMCBRIDE WILLIAM J·Filed 2012·Granted May 21, 2013·19 cites·33 claims
- 0497US8435539B2Delivery system for cytotoxic drugs by bispecific antibody pretargetingMCBRIDE WILLIAM J·Filed 2010·Granted May 7, 2013·34 cites·10 claims
- 0597US8398956B2In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agentsMCBRIDE WILLIAM J·Filed 2011·Granted Mar 19, 2013·20 cites·13 claims
- 0697US8202509B2Methods and compositions for improved F-18 labeling of proteins, peptides and other moleculesMCBRIDE WILLIAM J·Filed 2010·Granted Jun 19, 2012·26 cites·54 claims
- 0797US8147800B2Methods and compositions for F-18 labeling of proteins, peptides and other moleculesMCBRIDE WILLIAM J·Filed 2011·Granted Apr 3, 2012·30 cites·22 claims
- 0896US8496912B2In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agentsIMMUNOMEDICS INC·Filed 2013·Granted Jul 30, 2013·16 cites·26 claims
- 0995US9352036B2Delivery system for cytotoxic drugs by bispecific antibody pretargetingIMMUNOMEDICS INC·Filed 2013·Granted May 31, 2016·12 cites·16 claims
- 1095US9028800B2Methods and compositions for improved F-18 labeling of proteins, peptides and other moleculesIMMUNOMEDICS INC·Filed 2014·Granted May 12, 2015·12 cites·15 claims
- 1195US8758726B2Methods and compositions for improved F-18 labeling of proteins, peptides and other moleculesIMMUNOMEDICS INC·Filed 2013·Granted Jun 24, 2014·11 cites·13 claims
- 1295US8709382B2Methods and compositions for improved F-18 labeling of proteins, peptides and other moleculesIMMUNOMEDICS INC·Filed 2013·Granted Apr 29, 2014·14 cites·28 claims
- 1394US9115172B2Methods and compositions for improved F-18 labeling of proteins, peptides and other moleculesIMMUNOMEDICS INC·Filed 2014·Granted Aug 25, 2015·7 cites·25 claims
- 1494US8632752B2In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agentsIMMUNOMEDICS INC·Filed 2013·Granted Jan 21, 2014·9 cites·26 claims
- 1593US8889100B2Methods and compositions for improved F-18 labeling of proteins, peptides and other moleculesIMMUNOMEDICS INC·Filed 2014·Granted Nov 18, 2014·6 cites·14 claims
- 1693US8617518B2Methods and compositions for improved F-18 labeling of proteins, peptides and other moleculesIMMUNOMEDICS INC·Filed 2013·Granted Dec 31, 2013·8 cites·9 claims
- 1793US8545809B2Methods and compositions for improved 18F labeling of proteins, peptides and other moleculesD SOUZA CHRISTOPHER A·Filed 2011·Granted Oct 1, 2013·18 cites·41 claims
- 1892US8153100B2Methods and compositions for F-18 labeling of proteins, peptides and other moleculesMCBRIDE WILLIAM J·Filed 2009·Granted Apr 10, 2012·19 cites·27 claims
- 1989US8652484B2Delivery system for cytotoxic drugs by bispecific antibody pretargetingIMMUNOMEDICS INC·Filed 2012·Granted Feb 18, 2014·5 cites·15 claims
- 2074US2024131175A1Optimized transglutaminase site-specific antibody conjugationREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 2162US11786603B2Optimized transglutaminase site-specific antibody conjugationREGENERON PHARMA·Filed 2017·Granted Oct 17, 2023·0 cites·32 claims
- 2262US2017283442A1Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other MoleculesIMMUNOMEDICS INC·Filed 2017·Application pending·0 cites
- 2361US2015307524A1Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other MoleculesIMMUNOMEDICS INC·Filed 2015·Application pending·0 cites
- 2460US2016250350A1Delivery system for cytotoxic drugs by bispecific antibody pretargetingIMMUNOMEDICS INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →